Gestational Trophoblastic Disease
What is Gestational Trophoblastic Disease?
Gestational trophoblastic disease is a rare group of conditions that happen when abnormal cells grow inside the uterus after conception. These cells come from tissue that normally forms the placenta during pregnancy. Instead of developing into a healthy pregnancy, the cells grow abnormally and can form tumors.
Most cases are not cancerous and can be treated successfully. The most common type is called a molar pregnancy, which occurs when fertilization goes wrong. In rare cases, the abnormal cells can become cancerous and spread to other parts of the body. Early detection and proper care lead to very good outcomes for most people.
This condition affects about 1 in every 1,000 pregnancies in the United States. Women at higher risk include those under 20 or over 35 years old. With proper medical monitoring and care, most people recover completely and can have healthy pregnancies in the future.
Symptoms
- Vaginal bleeding during early pregnancy, often heavier than normal
- Severe nausea and vomiting that goes beyond typical morning sickness
- Uterus that grows faster or larger than expected for the stage of pregnancy
- High blood pressure developing early in pregnancy
- Pelvic pressure or pain in the lower abdomen
- Passing grape-like tissue or blood clots from the vagina
- Signs of hyperthyroidism including rapid heartbeat and tremors
- Anemia causing tiredness and weakness
Some people may have no symptoms at first. The condition is often discovered during routine prenatal ultrasounds or blood tests when hormone levels appear unusually high for the pregnancy stage.
Concerned about Gestational Trophoblastic Disease? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Gestational trophoblastic disease begins when something goes wrong during fertilization. In a complete molar pregnancy, an egg with no genetic material is fertilized by one or two sperm. The result is tissue with only paternal genes and no embryo. In a partial molar pregnancy, two sperm fertilize one normal egg, creating abnormal tissue alongside some fetal tissue. These fertilization errors cause cells to grow abnormally instead of forming a healthy pregnancy.
Several factors increase your risk. Age plays a significant role, with women under 20 or over 40 at higher risk. Having a previous molar pregnancy raises your chance of another by about 1 to 2 percent. Certain ethnic backgrounds have higher rates, particularly in Southeast Asia and the Philippines. A history of miscarriage and low levels of certain vitamins may also contribute to risk.
How it's diagnosed
Doctors diagnose gestational trophoblastic disease through a combination of tests. A pelvic ultrasound shows characteristic patterns that look different from normal pregnancy. Blood tests measure human chorionic gonadotropin, a pregnancy hormone that reaches very high levels with this condition. Placental isoenzymes may also be measured to help identify abnormal placental tissue.
After diagnosis, your doctor will determine what type and stage you have. This may involve chest X-rays, CT scans, or MRI to check if abnormal cells have spread. Regular blood tests track hormone levels over time to monitor your response to care. Talk to your doctor about specialized testing and monitoring for this condition.
Treatment options
- Dilation and curettage to remove abnormal tissue from the uterus
- Regular blood tests to monitor hormone levels until they return to normal
- Chemotherapy for cancerous forms that have spread beyond the uterus
- Hysterectomy in rare cases when other options are not suitable
- Birth control for 6 to 12 months after care to prevent pregnancy during monitoring
- Follow-up appointments every few weeks to ensure complete recovery
- Nutritional support to address anemia and maintain overall health
- Emotional support and counseling to process pregnancy loss
Frequently asked questions
The survival rate is very high with proper care. Nearly 100 percent of people with non-cancerous forms recover completely. Even for cancerous types that have spread, cure rates exceed 90 percent with chemotherapy. Early detection and regular monitoring lead to excellent outcomes.
Yes, most people go on to have healthy pregnancies after full recovery. Doctors typically recommend waiting 6 to 12 months after your hormone levels return to normal. The risk of having another molar pregnancy is about 1 to 2 percent, slightly higher than the general population. Your doctor will monitor future pregnancies more closely with early ultrasounds.
Both involve pregnancy loss, but they have different causes. A miscarriage happens when a developing embryo or fetus stops growing, usually due to genetic problems. Gestational trophoblastic disease occurs when abnormal placental cells grow instead of a normal pregnancy developing. The tissue growth patterns and hormone levels differ significantly between the two conditions.
Monitoring includes regular blood tests to measure hormone levels, usually weekly at first. Your doctor checks that levels drop to zero and stay there. You will also have physical exams and possibly chest X-rays. This monitoring typically continues for 6 to 12 months to ensure the condition does not return.
Pregnancy produces the same hormone that doctors use to monitor for disease recurrence. Getting pregnant during monitoring would make it impossible to tell if rising hormone levels mean a new pregnancy or returning disease. Waiting ensures doctors can accurately track your recovery and catch any problems early.
Cancerous forms may cause continued vaginal bleeding after tissue removal. Hormone levels may stay high or rise instead of dropping to normal. Some people develop symptoms like persistent cough, chest pain, or abdominal pain if cells spread to the lungs or other organs. Regular monitoring catches these changes early when they are most treatable.
Most cases are not hereditary and do not run in families. The condition results from random errors during fertilization rather than inherited genetic problems. Having a blood relative with the condition does not significantly increase your risk. However, your own history of molar pregnancy does slightly raise your risk for future pregnancies.
Treatment length varies by type and stage. Removing the abnormal tissue takes one day as an outpatient procedure. Monitoring hormone levels afterward continues for 6 to 12 months. If chemotherapy is needed for cancerous types, it may last several months depending on how the cells respond.
There is no known way to prevent this condition since it results from random fertilization errors. Maintaining good overall health and getting adequate nutrition may help support healthy pregnancies. Women over 40 who are done having children might consider this when planning pregnancies. Regular prenatal care helps with early detection if it does occur.
Many people experience grief similar to other pregnancy losses. The need for ongoing monitoring and avoiding pregnancy can feel overwhelming. Anxiety about cancer risk is common even though outcomes are usually very good. Support groups, counseling, and talking openly with your healthcare team can help you process these feelings and move forward.